Increasing evidence suggests that the constitutive activation of Rheb has beneficial effects against neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). This evidence concerns the gene RHEB and early-onset autosomal dominant Alzheimer disease.